Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme

BackgroundGliomas are the most common intracranial tumors and are classified as I–IV. Among them, glioblastoma multiforme (GBM) is the most common invasive glioma with a poor prognosis. New molecular biomarkers that can predict clinical outcomes in GBM patients must be identified, which will help co...

Full description

Bibliographic Details
Main Authors: Ji’an Yang, Long Wang, Zhou Xu, Liquan Wu, Baohui Liu, Junmin Wang, Daofeng Tian, Xiaoxing Xiong, Qianxue Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Genetics
Subjects:
glioblastoma
GEO
TCGA
WGCNA
prognosis biomarkers
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.00253/full

Internet

https://www.frontiersin.org/article/10.3389/fgene.2020.00253/full

Similar Items